Back to search

Article

Safety and Tolerability of Low-Dose Full-Spectrum Cannabidiol in Long-Term Virally Suppressed Adults with HIV: A Randomized Double-Blind Placebo-Controlled Trial

2026-03-24

Abstract excerpt

<h4>Introduction</h4> People with long-term virologically suppressed HIV (PWH) experience chronic inflammation. Beneficial effects such as lower levels of inflammation were reported for cannabis-based medicine but data on the safety of standardized low-dose full-spectrum cannabidiol (CBD) are limited. <h4>Methods</h4> This double-blind randomized placebo-controlled trial ( NCT05306249 ) included 80 ART-treated...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
11adcf76-7cb0-5ee4-9fc2-b2de4dae284b
DOI
10.64898/2026.03.21.26348972
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Safety and Tolerability of Low-Dose Full-Spectrum Cannabidiol in Long-Term Virally Suppressed Adults with HIV: A Randomized Double-Blind Placebo-Controlled TrialDOI 10.64898/2026.03.21.26348972
Select a neighboring publication to make it the new centre.